Novartis wants Japan to link drug price to patient outcomes

to The Nikkei in a recent interview. Japan has never implemented such a payment scheme. At issue is Kymriah, a new treatment for acute lymphoblastic leukemia in children and young adults. Kymriah in August became the first CAR-T cell therapy — one that …
( read original story …)


Related Post

Rugby: Joseph, Brown expand on Japan's attack...
views 105
New Japan coach Jamie Joseph has often stressed th...
The World War Two heroes reduced to skin and bone ...
views 83
These shocking photographs show the skeletal state...
B.C. announces first step in province-wide earthqu...
views 92
Her weekly segment, Science Smarts, answers viewer...
Japanese banks eye cross-group custody services me...
views 113
The two aim to integrate Trust & Custody Servi...
Why didn’t Japan’s First Lady speak to...
views 79
Japan woke up with surprise on Friday morning to s...
Japan, PH extend liquidity buffer deal
views 55
The central banks of the Philippines and Japan on ...
Ex-England striker Jay Bothroyd suffers blackout o...
views 51
Bothroyd, 35, is a teammate of Thailand internatio...
Death by overwork: Pressure mounts on Japan to act
views 103
Millions of Japanese people are in danger of worki...
PH offers 5 sectors to Japan investors
views 116
Investors would be particularly invited to do busi...
Japan Plans to Build Underground Repositories for ...
views 88
TOKYO – The Japanese government unveiled on Friday...